Albert S. Chiou
Tracked across 1 events · 7 articles · First seen May 07, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Albert S. Chiou, a Clinical Professor at Stanford University Medical Center, commented on the exciting results of the Soquelitinib trial, highlighting its potential to address limitations of current atopic dermatitis therapies.
May 07, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Albert S. Chiou live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard